On January 22, 2020, Interpace Biosciences, Inc. named Edward Chan and Robert Gorman to the Compensation & Management Development Committee of the Board. Director Joseph Keegan no longer serves on the Compensation & Management Development Committee. On the same date, the company named Edward Chan and Eric Lev to the Nominating and Corporate Governance Committee of the Board. On the same date, the company named Eric Lev as Chair to a newly created Compliance and Regulatory Committee and named Edward Chan and Robert Gorman as such Committee members.